BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14512493)

  • 1. Reliability of PSA testing remains unclear.
    Ciatto S
    BMJ; 2003 Sep; 327(7417):750. PubMed ID: 14512493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostatic specific antigen in practice in 1997].
    Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
    Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of prostate volume on the diagnostic parameters related to PSA and clinicopathological features of prostate cancer].
    Kimura G; Kimata R; Saito Y; Yoshida K; Nishimura T
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():479-85. PubMed ID: 12599623
    [No Abstract]   [Full Text] [Related]  

  • 4. PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.
    Greiver M; Rosen N
    CMAJ; 2000 Mar; 162(6):789-90. PubMed ID: 10750465
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostate cancer and prostate specific antigen screening].
    Camici M
    Minerva Med; 2004 Feb; 95(1):25-34. PubMed ID: 15041924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PSA level--is 4.0 ng/ml as upper limit too high].
    Aktuelle Urol; 2005 Jun; 36(3):181-8. PubMed ID: 16001334
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen (PSA) should drive doing prostate biopsies.
    Loeb S; Catalona WJ
    Urol Oncol; 2012; 30(1):1-2. PubMed ID: 21458316
    [No Abstract]   [Full Text] [Related]  

  • 9. The case for prostate cancer screening.
    Andriole GL
    Semin Urol; 1993 May; 11(2):50-3. PubMed ID: 7689738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer screening: the need for problem-solving that puts men's interests first.
    Holmberg L
    Eur Urol; 2009 Jul; 56(1):34-7. PubMed ID: 19394132
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer.
    Kamoi K; Babaian RJ
    Semin Oncol; 1999 Apr; 26(2):140-9. PubMed ID: 10597725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of free prostate specific antigen serum level and its related parameters in the diagnosis of prostate cancer.
    Haroun AA; Hadidy AS; Awwad ZM; Nimri CF; Mahafza WS; Tarawneh ES
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):291-7. PubMed ID: 21422628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of free prostate-specific antigen measurement in prostate-specific antigen screening for prostate cancer.
    Johnson L
    Clin Prostate Cancer; 2002 Dec; 1(3):142-4. PubMed ID: 15046688
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
    Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in Prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥ 100).
    Roobol MJ; Schröder FH; van Leenders GL; Hessels D; van den Bergh RC; Wolters T; van Leeuwen PJ
    Eur Urol; 2010 Dec; 58(6):893-9. PubMed ID: 20933321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSA screening.
    Cohen S; Schiff S; Kelty P
    Med Health R I; 2005 Mar; 88(3):90-1. PubMed ID: 15915782
    [No Abstract]   [Full Text] [Related]  

  • 17. PSA screening: the bottom line.
    Elhilali MM
    CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
    [No Abstract]   [Full Text] [Related]  

  • 18. [PSAD and PSA-AD in the early diagnosis of cancer of the prostate].
    Allepuz Losa C; Sanz JI; Carela J; Benejam J; García-Miralles R; Rioja Sanz LA
    Actas Urol Esp; 1997 Oct; 21(9):843-51. PubMed ID: 9471867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen density can help avoid unnecessary prostate biopsies at prostate specific antigen range of 4-10 ng/ml.
    Lodeta B; Benko G; Car S; Filipan Z; Stajcar D; Dujmović T
    Acta Clin Croat; 2009 Jun; 48(2):153-5. PubMed ID: 19928413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
    Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.